WCN25-2942 GLOMERULOSCLEROSIS IS INFLUENCED BY THE MAPK SIGNALING PATHWAY AND THE EGR1 TRANSCRIPTION FACTOR

WCN25-2942 GLOMERULOSCLEROSIS IS INFLUENCED BY THE MAPK SIGNALING PATHWAY AND THE EGR1 TRANSCRIPTION FACTOR

Saved in:

Bibliographic Details
Main Authors:	Heitor Braz, Maria de Souza
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924028523
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The transcription factor EGR1 localizes to the nucleolus and is linked to suppression of ribosomal precursor synthesis.
by: Donatella Ponti, et al.
Published: (2014-01-01)

WCN25-63 Refractory Nephrotic Syndrome in Focal and Segmental Glomerulosclerosis by PMM2 Genetic Variant
by: Jaime Arturo Dulce M, et al.
Published: (2025-02-01)

Induction of Senescence in Lung Cancer Cells by Qidongning Formula via the Transcription Factor EGR1
by: Di Zhou MD, et al.
Published: (2025-02-01)

High-energy Jet Emission from GRS 1758–258 and 1E 1740.7–2942 with INTEGRAL?
by: James Rodi, et al.
Published: (2025-01-01)

WCN25-3085 MOLECULAR ALTERATIONS OF PODOCYTES IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND IMMUNOGLOBULIN A NEPHROPATHY: AN EXPLORATORY STUDY
by: Natalia Semenova, et al.
Published: (2025-02-01)

WCN25-3115 MOLECULAR ALTERATIONS OF PODOCYTES IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND IMMUNOGLOBULIN A NEPHROPATHY: AN EXPLORATORY STUDY
by: Vladimir Dobronravov, et al.
Published: (2025-02-01)

The roles of MAPK signaling pathway in ovarian folliculogenesis
by: Hong Zhao, et al.
Published: (2025-07-01)

WCN25-2195 CLINICAL COURSE AND OUTCOME OF ADULT PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH KIDNEY FUNCTION LOSS ON PRESENTATION
by: Nazarul Hassan Jafry, et al.
Published: (2025-02-01)

WCN25-1675 ANTI-NEPHRIN ANTIBODIES IN ADULT CHINESE PATIENTS WITH MINIMAL CHANGE DISEASE AND PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
by: Yue Shu, et al.
Published: (2025-02-01)

WCN25-3905 TMEM30A downregulation initiate podocyte injury through reducing glycolysis in focal segmental glomerulosclerosis
by: LI GUISEN
Published: (2025-02-01)

WCN25-2069 RENAL-LOSS HYPOKALEMIA COMPLICATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS PRESENTING AS NEPHROTIC SYNDROME: A RARE CASE
by: Calvin Kurnia Mulyadi, et al.
Published: (2025-02-01)

WCN25-1081 STUDY OF CLINICAL SIGNIFICANCE OF IgM AND C3 GLOMERULAR DEPOSITIS IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
by: Prajit mazumdar, et al.
Published: (2025-02-01)

Attenuated Late-Phase Arc Transcription in the Dentate Gyrus of Mice Lacking Egr3
by: Amanda Maple, et al.
Published: (2017-01-01)

WCN24-1899 RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANTATION
by: Adriana M. Lituma, et al.
Published: (2024-04-01)

WCN25-2015 EFFICACY OF RITUXIMAB IN MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS : A SINGLE CENTRE EXPERIENCE FROM INDIA
by: Harshkumar Patel, et al.
Published: (2025-02-01)

Transcription factor WRKY complexes in plant signaling pathways
by: Xujun Chen, et al.
Published: (2025-04-01)

WCN24-29 SPONTANEOUS REMISSION OF POST TRANSPLANT RECURRENT FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS
by: Mohamad Bassam Said
Published: (2024-04-01)

Direct transcriptional control of a p38 MAPK pathway by the circadian clock in Neurospora crassa.
by: Teresa M Lamb, et al.
Published: (2011-01-01)

WCN25-907 CLINICAL CHARACTERISTICS IN CHILDREN WITH MONOGENIC AND NON-GENETIC STEROID-RESISTANT NEPHROTIC SYNDROME DUE TO FOCAL SEGMENTAL GLOMERULOSCLEROSIS TREATED WITH CALCINEURIN INHIBITORS
by: Larisa Prikhodina
Published: (2025-02-01)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
by: Taryn E Gillies, et al.
Published: (2020-10-01)

MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential
by: Jun Xie, et al.
Published: (2025-07-01)

Recent advances of P38MAPK signaling pathway in diabetic nephropathy
by: Ma Dong-mei, et al.
Published: (2021-01-01)

Androgen Modulates Functions of Endothelial Progenitor Cells through Activated Egr1 Signaling
by: Yizhou Ye, et al.
Published: (2016-01-01)

WCN24-281 A STUDY ON THE FACTORS AFFECTING OUTCOMES OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND THE IMPORTANCE OF GENETIC DIAGNOSTICS IN PREDICTING OUTCOMES
by: KAJAREE GIRI, et al.
Published: (2024-04-01)

Conditioned Medium Derived From Human Dental Follicle Mesenchymal Stem Cells Alleviates Macrophage Proinflammatory Responses Through MAPK-ERK-EGR1 Axis
by: Chuhan Zhang, et al.
Published: (2024-01-01)

The Significance of MAPK Signaling Pathway in the Diagnosis and Subtype Classification of Intervertebral Disc Degeneration
by: Yong Liu, et al.
Published: (2025-03-01)

PELI2 inhibits colorectal cancer development through MAPK signaling pathway
by: Jialin Liu, et al.
Published: (2025-06-01)

Icariin Promotes the Migration of BMSCs In Vitro and In Vivo via the MAPK Signaling Pathway
by: Feng Jiao, et al.
Published: (2018-01-01)

WCN24-2707 Focal and Segmental Glomerulosclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a Case Report
by: Katia Olga Teresa Hernández Torres, et al.
Published: (2024-04-01)

Thymic Regulatory T Cell Development: Role of Signalling Pathways and Transcription Factors
by: Mark Engel, et al.
Published: (2013-01-01)

Mechanism and development direction of CO2-EGR
by: ZHU Haonan, CAO Cheng, ZHANG Liehui, ZHAO Yulong, PENG Xian, ZHAO Zihan, CHEN Xingyu
Published: (2024-12-01)

Growth factor independence 1 ameliorates osteoarthritis by inhibiting chondrocyte ferroptosis via inactivation of MAPK signaling pathway
by: Xiaoyu Jin, et al.
Published: (2025-09-01)

Early Growth Response 1 (Egr1) Is a Transcriptional Activator of NOX4 in Oxidative Stress of Diabetic Kidney Disease
by: Fang Hu, et al.
Published: (2018-01-01)

WCN25-589 IDENTIFICATION OF FACTORS INFLUENCING THE PROGRESSION OF COMORBIDITY IN HD PATIENTS
by: Konstantin Vishnevskii, et al.
Published: (2025-02-01)

WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION
by: Sandra Liliana Borda Galindo, et al.
Published: (2024-04-01)

Dapagliflozin ameliorates intestinal stem cell aging by regulating the MAPK signaling pathway in Drosophila
by: Jinhua Yan, et al.
Published: (2025-04-01)

SERPINB4 Promotes Keratinocyte Inflammation via p38MAPK Signaling Pathway
by: Yanan Zhang, et al.
Published: (2023-01-01)

Rivaroxaban Ameliorates Sunitinib-Induced Injury of Cardiomyocytes via Repressing MAPK Signaling Pathway
by: Ying Qian, et al.
Published: (2025-01-01)

Mechanisms of the JNK/p38 MAPK signaling pathway in drug resistance in ovarian cancer
by: Yu-Ting Ma, et al.
Published: (2025-04-01)

Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
by: Liang Zhu, et al.
Published: (2025-02-01)